Block trade of shares in Swedish Orphan Biovitrum (SE) — SEK 231 million

Carnegie acted as sole broker in the block trade of slightly more than 6 million shares in Swedish Orphan Biovitrum, a leading European specialty pharmaceutical company.March 2013.